Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression
- PMID: 11805144
- PMCID: PMC2193612
- DOI: 10.1084/jem.20011450
Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression
Abstract
Ultraviolet (UV) radiation plays a critical role in the induction of nonmelanoma skin cancer. UV radiation is also immune suppressive, and the immune suppression induced by UV irradiation has been identified as a major risk factor for skin cancer induction. Previously, we showed that UV exposure activates a cytokine cascade involving prostaglandin (PG)E(2), interleukin (IL)-4, and IL-10 that induces immune suppression. However, the earliest molecular events that occur immediately after UV exposure, especially those upstream of PGE2, are not well defined. UV-irradiated keratinocytes secrete the inflammatory phospholipid mediator, platelet-activating factor (PAF). Because PAF upregulates the production of immunomodulatory compounds, including PGE2, we tested the hypothesis that UV-induced PAF activates cytokine production and initiates UV-induced immune suppression. Both UV and PAF activated cyclooxygenase (COX)-2 and IL-10 reporter gene construct transcription. PAF mimicked the effects of UV in vivo and suppressed delayed-type hypersensitivity (DTH). Furthermore, immune suppression was blocked when UV-irradiated mice were injected with PAF receptor antagonists. In addition to the well-known role of PAF as a proinflammatory lipid mediator, we propose that the PAF receptor senses cellular damage through the recognition of PAF and/or PAF-like molecules, such as oxidized phosphatidylcholine, which activates cytokine transcription and induces systemic immune suppression.
Figures






Similar articles
-
Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression.Toxicol Appl Pharmacol. 2004 Mar 15;195(3):331-8. doi: 10.1016/j.taap.2003.07.014. Toxicol Appl Pharmacol. 2004. PMID: 15020195
-
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis.J Immunol. 1998 Aug 15;161(4):1954-61. J Immunol. 1998. PMID: 9712066
-
Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production.J Invest Dermatol. 2000 Aug;115(2):267-72. doi: 10.1046/j.1523-1747.2000.00058.x. J Invest Dermatol. 2000. PMID: 10951245
-
Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.Prog Lipid Res. 2016 Jul;63:14-27. doi: 10.1016/j.plipres.2016.03.004. Epub 2016 Apr 9. Prog Lipid Res. 2016. PMID: 27073146 Free PMC article. Review.
-
Activation of the phospholipase/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists.J Ocul Pharmacol Ther. 1995 Fall;11(3):329-37. doi: 10.1089/jop.1995.11.329. J Ocul Pharmacol Ther. 1995. PMID: 8590265 Review.
Cited by
-
Exposure to solar ultraviolet radiation establishes a novel immune suppressive lipidome in skin-draining lymph nodes.Front Immunol. 2023 Jan 20;13:1045731. doi: 10.3389/fimmu.2022.1045731. eCollection 2022. Front Immunol. 2023. PMID: 36741361 Free PMC article.
-
Brucella abortus synthesizes phosphatidylcholine from choline provided by the host.J Bacteriol. 2006 Mar;188(5):1929-34. doi: 10.1128/JB.188.5.1929-1934.2006. J Bacteriol. 2006. PMID: 16484204 Free PMC article.
-
Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth.Int J Mol Sci. 2018 Oct 11;19(10):3109. doi: 10.3390/ijms19103109. Int J Mol Sci. 2018. PMID: 30314274 Free PMC article.
-
The contribution of Langerhans cells to cutaneous malignancy.Trends Immunol. 2010 Dec;31(12):460-6. doi: 10.1016/j.it.2010.10.001. Epub 2010 Nov 9. Trends Immunol. 2010. PMID: 21071271 Free PMC article. Review.
-
Thermal Burn Injury Generates Bioactive Microvesicles: Evidence for a Novel Transport Mechanism for the Lipid Mediator Platelet-Activating Factor (PAF) That Involves Subcellular Particles and the PAF Receptor.J Immunol. 2020 Jul 1;205(1):193-201. doi: 10.4049/jimmunol.1901393. Epub 2020 May 20. J Immunol. 2020. PMID: 32434939 Free PMC article.
References
-
- Prescott, S.M., G.A. Zimmerman, D.M. Stafforini, and T.M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69:419–445. - PubMed
-
- McIntyre, T.M., G.A. Zimmerman, and S.M. Prescott. 1999. Biologically active oxidized phospholipids. J. Biol. Chem. 274:25189–25192. - PubMed
-
- Ishii, S., and T. Shimizu. 2000. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39:41–82. - PubMed
-
- Penn, I. 2000. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 23:101–113. - PubMed
-
- Fisher, M.S., and M.L. Kripke. 1982. Suppressor T lymphocytes control the development of primary skin cancers in UV-irradiated mice. Science. 216:1133–1134. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials